Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Refractory or Relapsed Solid Tumors 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

Specimen Handling 2Endoscopy 2tremelimumab 1futibatinib 1durvalumab 1Taxes 1Risk Assessment 1Ramucirumab 1Radiofrequency Ablation 1Paclitaxel 1Oxaliplatin 1Observation 1Mass Screening 1Magnetic Resonance Spectroscopy 1Leucovorin 1Itraconazole 1Folfox protocol 1Fluorouracil 1Breath Tests 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Adenocarcinoma Of Esophagus × Itraconazole × Clear all
NCT06732388 2026-05-13

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

National Cancer Institute (NCI)

Phase 2 Not yet recruiting
64 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡